Search - tctmd.com

Displaying 341 - 360 of 2115

Sort: Relevancy | Date

Presentation TCT 2021

Special (Device/Drug) Approaches to Infarct Size Reduction

Presenter: Giovanni Luigi De Maria

November 05, 2021

Presentation TCT 2021

Evidence Gaps: What’s Needed in the New Guidelines?

Presenter: Duane Pinto

November 05, 2021

Presentation TCT 2021

TCT 606: Percutaneous Treatment of a Giant Saphenous Vein Graft Aneurysm

Presenter: Brandon Boyer

November 05, 2021

Presentation TCT 2021

Drug Therapy for No Re-Flow

Presenter: Somjot Brar

November 05, 2021

Presentation TCT 2021

How Do We Identify Patients With Microvascular Dysfunction and Define Their Risk (Pressure Wire, Angiography, MRI)?

Presenter: Adrian Banning

November 05, 2021

Presentation TCT 2021

Latest Evidence in the SPYRAL-HTN Clinical Program

Presenter: NULL

November 05, 2021

Presentation TCT 2021

Digital Health Apps in Cardiovascular Device Trials, From FDA Perspective

Presenter: George Van Hare

November 05, 2021

Presentation TCT 2021

TCT 604: Hemoptysis From SVG Aneurysm Fistulization to Bronchial Tree Sealed With Covered Stent to Aneurysm Entrance

Presenter: Christopher Wasco

November 05, 2021

Presentation TCT 2021

Management of High Thrombus Burden: What Is the Role of Aspiration/ Intravenous Antipletelets/Intracoronary Lytic?

Presenter: J. Dawn Abbott

November 05, 2021

Presentation TCT 2021

Evidence gaps: What’s Needed in the New Guidelines?

Presenter: David Cohen

November 05, 2021

Presentation TCT 2021

Digital Health Apps in Cardiovascular Device Trials, a Clinician's Perspective

Presenter: Mintu Turakhia

November 05, 2021

Presentation TCT 2021

Options for Immediate vs Staging Multivessel Revascularization in STEMI

Presenter: Timothy Henry

November 05, 2021

Presentation TCT 2021

Evidence Gaps: What’s Needed in the New Guidelines?

Presenter: Rasha Al-Lamee

November 05, 2021

Presentation TCT 2021

Left Atrial Appendage Interventions – Closing the Key Evidence Gaps to Move the Field Forward, From FDA Perspective

Presenter: Kan Fang

November 05, 2021

Presentation TCT 2021

Optimising Pharmacoinvasive Therapies for STEMI Patients Prior to PCI

Presenter: Robert Welsh

November 05, 2021

Presentation TCT 2021

“Critical Appraisal of Complications: How to Get (and Allow Yourself to Feel) Better”

Presenter: Sanjog Kalra

November 05, 2021

News Conference News TCT 2021

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

Todd Neale

November 05, 2021

Presentation TCT 2021

Continuous Mechanical Aspiration: Myocardial Perfusion and the Prevention of No Reflow

Presenter: Sahil Parikh

November 05, 2021

Presentation TCT 2021

TCT 550: Power-Carlino, A Novel Method to Overcome Difficult-to-Penetrate Proximal Cap

Presenter: Michael Megaly

November 05, 2021

Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Presenter: Meir Shinnar

November 05, 2021

Advertisement

Special (Device/Drug) Approaches to Infarct Size Reduction

Evidence Gaps: What’s Needed in the New Guidelines?

TCT 606: Percutaneous Treatment of a Giant Saphenous Vein Graft Aneurysm

Drug Therapy for No Re-Flow

How Do We Identify Patients With Microvascular Dysfunction and Define Their Risk (Pressure Wire, Angiography, MRI)?

Latest Evidence in the SPYRAL-HTN Clinical Program

Digital Health Apps in Cardiovascular Device Trials, From FDA Perspective

TCT 604: Hemoptysis From SVG Aneurysm Fistulization to Bronchial Tree Sealed With Covered Stent to Aneurysm Entrance

Management of High Thrombus Burden: What Is the Role of Aspiration/ Intravenous Antipletelets/Intracoronary Lytic?

Evidence gaps: What’s Needed in the New Guidelines?

Digital Health Apps in Cardiovascular Device Trials, a Clinician's Perspective

Options for Immediate vs Staging Multivessel Revascularization in STEMI

Evidence Gaps: What’s Needed in the New Guidelines?

Left Atrial Appendage Interventions – Closing the Key Evidence Gaps to Move the Field Forward, From FDA Perspective

Optimising Pharmacoinvasive Therapies for STEMI Patients Prior to PCI

“Critical Appraisal of Complications: How to Get (and Allow Yourself to Feel) Better”

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

Continuous Mechanical Aspiration: Myocardial Perfusion and the Prevention of No Reflow

TCT 550: Power-Carlino, A Novel Method to Overcome Difficult-to-Penetrate Proximal Cap

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content